| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-10 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.17 | 9e-07 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.24 | 1e-06 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.25 | 5e-06 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |